Improving CNS delivery and distribution of Huntington's disease therapies Published 2022-11-18 Download video MP4 360p Recommendations 1:09:59 HDSA RESEARCH WEBINAR: 2019 Year in Review 57:58 HDSA RESEARCH WEBINAR: All You Need To Know About PROOF-HD 02:49 A patient's experience with chronic sinusitis. 43:23 Generation HD1 - Preliminary Data Analysis & Next Steps 04:35 Defining distinct cognitive phenotypes in multiple sclerosis 11:45 6 Verbal Tricks To Make An Aggressive Person Sorry 01:25 Exercise as a tool to protect against cognitive decline 1:42:12 HDSA Research Forum (Part One) 05:26 the direct & indirect PK/PD models & dose fractionation studies 39:49 Contextualizing Patient Centeredness in Outcomes for Intracerebral Hemorrhage 02:46 Guidance for starting a career in telestroke 02:47 Bringing Medicines to the Body: PK/PD & Clinical Pharmacology 14:57 How to spot autism in High Masking Autistic Women - What’s behind the mask? 07:37 Improvement in thrombolysis care metrics by race and ethnicity 03:25 Dr. Bell speaks about the Linx procedure 13:28 Joe Tracini on BPD, addiction, and not dying by suicide 12:36 Cognitive Behavioral Therapy Exercises (FEEL Better!) 01:28 Exciting developments in sleep research 02:40 New Rare Treatment for Enlarged Prostate 03:22 Reversing Type 2 Diabetes with Bariatric Surgery I Bob's Experience Similar videos 37:43 RNAi-based huntingtin lowering in the central nervous system: a new potential HD therapeutic. 52:52 Keynote - HD Research Update from Dr. Claassen (Vanderbilt) - UF Huntington Disease Symposium 24:16 E14.2 Therapeutic advances in Huntingtons disease with relevance to other repeat expansion disorders 59:20 Anastasia Khvorova: RNAi-based Therapeutics: 2018 Outlook 33:16 AAV Gene Therapy to CNS: Past, Present and Future - Miguel Sena-Esteves 42:19 Patient Advocacy and Therapeutic Development for Huntington’s Disease 1:20:57 Webinar: Elisa Konofagou: Focused Ultrasound for the Treatment of Central Nervous System Diseases 42:25 How Critical Illness Affects the Brain... and Vice Versa 52:25 HDYO Webinar Series: UniQure's HD Research Update 44:37 New therapies for Huntington's Disease | Professors Sarah Tabrizi & Gillian Bates 06:57 Rajeev Kumar, MDS 2022: ANX005, a humanized mAb for Huntington’s disease, the phase 2 study results 48:01 Research Webinar: Huntingtin ASOs 26:54 MR Image-Guided Transfection of the CNS with Focused Ultrasound and Brain-Penetrating Nanoparticles 1:01:09 Intrabodies A New Drug Class and Potential New Drug INT41 for Huntington s Disease 30:53 Device based therapeutics for CNS disease by Marcie Glicksman Head of Biology from EnClear Therapies 45:51 CSAR Lecture: Professor Sarah Tabrizi, University College London 1:03:28 Keynote: AAV-mediated gene therapy to the central nervous system: prospect for Angelman syndrome 4:54:45 NIMH Workshop: Gene-based Therapeutics for Rare Genetic Neurodevelopmental Psychiatric Disorders 1:03:02 PLENARY: New genetic therapies for neurodegeneration, Sarah Tabrizi More results